China National Center for Cardiovascular Diseases: Clinical Trials

267 trials sponsored by China National Center for Cardiovascular Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

84 unknown, 66 completed, 65 recruiting, 42 not yet recruiting. 110 Not applicable, 30 Phase 4, 4 Phase 2, 4 Phase 3, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable110Unknown 36, Recruiting 26, Completed 24, Not yet recruiting 22, Active not recruiting 2
Phase 430Recruiting 10, Not yet recruiting 7, Completed 6, Unknown 6, Active not recruiting 1
Phase 24Unknown 3, Recruiting 1
Phase 34Unknown 3, Completed 1
Phase 13Unknown 2, Recruiting 1
Early Phase 12Completed 1, Recruiting 1

Follow China National Center for Cardiovascular Diseases: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
IVUS-Guided Sirolimus-Coated Balloon Versus Sirolimus-Eluting Stent for De Novo Large Vessel Lesions in ACS
IVUS-Guided Sirolimus-Coated Balloon, IVUS-Guided Sirolimus-Eluting Stent - Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
Not applicableNot yet recruitingChina National Center for Cardiovascular Diseases1502026-12-012026-10-15
Ultrasound Guided Leadless Pacemaker Implantation
Transthoracic echocardiography-guided, Conventional fluoroscopy-guided, Leadless pacemkaer - Leadless Pacemaker, Transthoracic Echocardiography
Not applicableNot yet recruitingChina National Center for Cardiovascular Diseases2882026-10-202026-10-05
TOP-CABG Trial: Follow-up Extension (TOP-CABG FE)
Coronary Artery Disease, Coronary Artery Bypass Grafting
Not yet recruitingChina National Center for Cardiovascular Diseases22902026-10-152026-10-13
Effect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or Obesity
Mazdutide, Placebo - Obesity & Overweight, Coronary Heart Disease
Phase 4RecruitingChina National Center for Cardiovascular Diseases1162026-09-142026-10-13
A Prospective Multicenter Real-World Registry of Quantitative Flow Ratio-Guided Coronary REvascularization and QuAlity evaLuation
Coronary Artery Disease
RecruitingChina National Center for Cardiovascular Diseases100002026-08-262026-09-24
Construction and Validation of a Coronary Artery Disease-Specific Large Language Model and Its Evaluation Framework (CorAI)
No Intervention: Observational Cohort - Coronary Heart Disease (CHD), Artifical Intelligence
Not yet recruitingChina National Center for Cardiovascular Diseases6402026-08-172026-08-14
A Comparative Study of Percutaneous Pulsed Field Ablation Guided by Ultrasound Alone Versus Fluoroscopy in Patients With Atrial Fibrillation
Percutaneous pulsed field ablation is performed under ultrasound-only guidance in patients with paroxysmal atrial fibrillation., Patients with paroxysmal atrial fibrillation underwent percutaneous pulsed field ablation under fluoroscopic guidance. - Paroxysmal Atrial Fibrillation (PAF)
Not applicableNot yet recruitingChina National Center for Cardiovascular Diseases2762026-08-152026-08-13
PRECISE-AFMR I: Transcatheter Mitral Valve Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation in Patients at High Surgical Risk
Transcatheter Edge-to-Edge Repair - Atrial Functional, Mitral Regurgitation (MR)
Not applicableNot yet recruitingChina National Center for Cardiovascular Diseases1822026-08-012026-08-03
Micro-axial Flow Pump-Supported PCI in Complex Coronary Artery Disease With Ischemic LV Dysfunction
Microaxial pump-supported PCI, Optimal medical therapy (OMT) - Coronary Artery Disease (CAD)
Not applicableNot yet recruitingChina National Center for Cardiovascular Diseases4522026-08-012026-07-01
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT
icosapent ethyl (IPE), Standard LDL-C-Lowering Therapy - Coronary Artery Disease, Hyperlipidaemia
Phase 4Not yet recruitingChina National Center for Cardiovascular Diseases1002026-08-012026-08-13
Perioperative Transcutaneous Fluorescence Detection of GFR Trajectory for the Early Prediction and Diagnosis of CSA-AKI.
Acute Kidney Injury
RecruitingChina National Center for Cardiovascular Diseases4362026-07-172026-08-06
STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump
Warfarin (INR 2-3) with placebo, Warfarin (INR 2-3) with aspirin - LVAD (Left Ventricular Assist Device) Thrombosis, LVAD
Phase 4Not yet recruitingChina National Center for Cardiovascular Diseases3702026-06-252026-06-12
Unipolar Voltage Mapping for Personalized Atrial Fibrillation Ablation
Unipolar QS-Potential Guided Catheter Ablation, Conventional Pulmonary Vein Isolation - Atrial Fibrillation (AF)
Not applicableRecruitingChina National Center for Cardiovascular Diseases2002026-06-202026-06-16
QFR-Guided Virtual Stenting for Preprocedural Physiological Optimization of Percutaneous Coronary Intervention: A Randomized Controlled Trial
Virtual Stenting-Guided PCI Optimization, Standard Angiography-Guided PCI - Coronary Artery Disease, Coronary Stenosis
Not applicableRecruitingChina National Center for Cardiovascular Diseases14722026-06-022026-07-06
Vasopressor Agents in Pulmonary Hypertension Crisis
Norepinephrine, Dopamine, Epinephrine - Pulmonary Arterial Hypertension (PAH), Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Not applicableNot yet recruitingChina National Center for Cardiovascular Diseases752026-06-012026-06-25
A Study of Using CARTO SOUND™ FAM to Guide Pulsed Field Ablation for Atrial Fibrillation
CARTO SOUND™ FAM System with Varipulse™ PFA Catheter - Atrial Fibrillation
Not applicableNot yet recruitingChina National Center for Cardiovascular Diseases702026-06-012026-05-18
Conscious Sedation Versus General Anesthesia for Pulsed Field Ablation in Paroxysmal Atrial Fibrillation
Local Anesthesia With Conscious Sedation, General Anesthesia, VARIPULSE Pulsed Field Ablation System - Paroxysmal Atrial Fibrillation
Not applicableRecruitingChina National Center for Cardiovascular Diseases3902026-06-012026-10-16
Effect of Finerenone on Myocardial Fibrosis and Cardiac Function in HFmrEF/HFpEF Patients
Oral finerenone, Placebo - Heart Failure
Phase 4Not yet recruitingChina National Center for Cardiovascular Diseases1042026-05-152026-05-13
rhBNP for Prevention of Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI)
Recombinant Human Brain Natriuretic Peptide (rhBNP), Normal Saline (Placebo) - AKI - Acute Kidney Injury, Cardiac Surgical Procedures
Phase 4Not yet recruitingChina National Center for Cardiovascular Diseases6942026-05-012026-06-01
Sirolimus-Coated vs Paclitaxel-Coated DCBs in ACS Treatment
Sirolimus-coated DCB, Paclitaxel-coated DCB - Acute Coronary Syndromes (ACS)
Not applicableNot yet recruitingChina National Center for Cardiovascular Diseases602026-05-012026-04-07

Showing 20 of 267. Sign in to see all of them.

Conditions studied

Coronary Artery Disease (55)  ·  Coronary Disease (22)  ·  Atrial Fibrillation (21)  ·  Hypertension (15)  ·  Cardiovascular Diseases (13)  ·  Stroke (12)  ·  Heart Defects, Congenital (10)  ·  Heart Failure (10)  ·  Cardiomyopathy, Hypertrophic (9)  ·  Diabetes Mellitus (8)  ·  Aortic Valve Stenosis (7)  ·  Acute Coronary Syndrome (6)  ·  Mitral Valve Insufficiency (6)  ·  Myocardial Infarction (6)  ·  Myocardial Ischemia (6)

Interventions

Captopril (3)  ·  Catheter Ablation (3)  ·  Metoprolol (3)  ·  Observation (3)  ·  Rivaroxaban (3)  ·  Spironolactone (3)  ·  Torsemide (3)  ·  empagliflozin (3)  ·  Angiography (2)  ·  Aspirin (2)  ·  Berberine (2)  ·  Clopidogrel (2)  ·  Coronary Angiography (2)  ·  Saline Solution (2)  ·  Transcatheter Aortic Valve Replacement (2)

Countries

China (231)  ·  Japan (1)  ·  United States (1)

Top investigators

Harlan M Krumholz, M.D., S.M. (6)  ·  Kefei Dou, MD, PhD (6)  ·  Lixin Jiang, MD, PhD (6)  ·  Zhe Zheng, MD,PhD (6)  ·  Harlan M Krumholz, MD, SM (5)  ·  Lixin Jiang, M.D., Ph.D. (5)  ·  Shoujun Li, MD (5)  ·  Bo Xu, MBBS (4)  ·  Chaowu Yan, PhD and MD (4)  ·  Jing Li, MD, PhD (4)  ·  Shengshou Hu, MD (4)  ·  Xin Yuan, PhD (4)  ·  Shengshou Hu, M.D. (3)  ·  Zhe Zheng, MD, PhD (3)

Results publications

PMID 31330187, PMID 31760820, PMID 34896621, PMID 26347918, PMID 27402231, PMID 28317428, PMID 29273661, PMID 29579607, PMID 30596995, PMID 32452896, PMID 33940549, PMID 34012407, PMID 34032839, PMID 34510911, PMID 35578345, PMID 36891906, PMID 42015174, PMID 12103262, PMID 12486652, PMID 12660385, PMID 15574551, PMID 1716178, PMID 17276178, PMID 17997359, PMID 18765433, PMID 18936041, PMID 19054243, PMID 19414839, PMID 19762724, PMID 20048204, PMID 21050973, PMID 21168339, PMID 21658561, PMID 21946776, PMID 22064599, PMID 22511657, PMID 22778141, PMID 24221838, PMID 24457276, PMID 24607563, PMID 24625726, PMID 24810757, PMID 24820759, PMID 24969506, PMID 25225745, PMID 25304853, PMID 25510395, PMID 25516034, PMID 25616815, PMID 25644851